TEST BANK NRNP6552 ADVANCED NURSE PRACTICE IN REPRODUCTIVE
HEALTH FINAL EXAM REVIEW WITH COMPLETE 300 REAL EXAM
140 QUESTIONS
TABLE OF CONTENTS
# TOPIC
1 Differentiate complex reproductive health presentations for accurate diagnosis and management
2 Integrate current evidence-based guidelines into individualized patient care plans
3 Critically evaluate pharmacologic and non-pharmacologic interventions for reproductive health conditions
4 Apply ethical and legal principles in sensitive reproductive health scenarios
5 NRNP 6552 FINAL EXAM
6 WALDEN
7 NEWEST 2026
8 2027 ACTUAL EXAM TEST BANK NRNP6552 ADVANCED NURSE PRACTICE IN REPRODUCTIVE
HEALTH FINAL EXAM REVIEW WITH COMPLETE 300 REAL EXAM QUESTIONS AND CORRECT
VERIFIED ANSWERS
9 ALREADY GRADED A+
10 MOST RECENT!!
11 Foundations of Advanced Nurse Practice in Reproductive Health
12 Applied Advanced Nurse Practice in Reproductive Health
13 Advanced Advanced Nurse Practice in Reproductive Health
14 Advanced Nurse Practice in Reproductive Health Review
ABSTRACT
Page 1
,This study document brings together 140 carefully worded exam questions drawn from NRNP
6552 FINAL EXAM (WALDEN) NEWEST 2026/ 2027 ACTUAL EXAM TEST BANK NRNP6552
ADVANCED NURSE PRACTICE IN REPRODUCTIVE HEALTH FINAL EXAM REVIEW WITH
COMPLETE 300 REAL EXAM QUESTIONS AND CORRECT VERIFIED ANSWERS/ ALREADY
GRADED A+ (MOST RECENT!!, with the strongest emphasis placed on Differentiate complex
reproductive health presentations for accurate diagnosis and management, Integrate current
evidence-based guidelines into individualized patient care plans and Critically evaluate
pharmacologic and non-pharmacologic interventions for reproductive health conditions. Every item
follows the wording style and level of reasoning you meet in the real paper, and each one is paired
with a clear rationale so the correct choice is never a guess. Work through the set at your own
pace, mark the questions that slow you down, then come back to them until the reasoning feels
automatic. Learners who revise this way walk into the exam room recognising the pattern behind
the questions instead of meeting them for the first time. Keep going - steady, honest practice is
what turns a difficult paper into a comfortable pass.
Q1 DIFFERENTIATE COMPLEX REPRODUCTIVE HEALTH PRESENTATIONS FOR ACCURATE
DIAGNOSIS AND MANAGEMENT
A patient with a history of recurrent vulvovaginal candidiasis (RVVC) presents with
persistent symptoms despite multiple courses of fluconazole. Recent culture
grows Candida glabrata. Which of the following is the most appropriate next step
in management?
A. Increase fluconazole dose to 200 mg daily for 14 days
B. Prescribe boric acid 600 mg intravaginally once daily for 14 days CORRECT
C. Switch to oral itraconazole 200 mg twice daily for 7 days
D. Use topical clotrimazole 1% cream for 7 days
RATIONALE: Candida glabrata is often resistant to fluconazole; boric acid is recommended as
first-line for azole-resistant glabrata infections. Increasing fluconazole dose or switching to
itraconazole may still fail due to intrinsic resistance. Topical clotrimazole is also less effective
against glabrata.
Page 2
,Q2 DIFFERENTIATE COMPLEX REPRODUCTIVE HEALTH PRESENTATIONS FOR ACCURATE
DIAGNOSIS AND MANAGEMENT
According to the U.S. Medical Eligibility Criteria for Contraceptive Use (US MEC),
which of the following represents a Category 4 condition for combined hormonal
contraceptives (CHCs)?
A. Migraine with aura at any age CORRECT
B. Well-controlled hypertension with blood pressure <140/90
C. History of gestational diabetes
D. Current smoker age 35 with no other risk factors
RATIONALE: Migraine with aura is a Category 4 (unacceptable health risk) for CHCs due to
increased stroke risk. Well-controlled hypertension is Category 3, gestational diabetes is
Category 2, and smoking alone in a person under 35 is Category 3 (Category 4 if over 35 and
smoking).
Q3 DIFFERENTIATE COMPLEX REPRODUCTIVE HEALTH PRESENTATIONS FOR ACCURATE
DIAGNOSIS AND MANAGEMENT
A 28-year-old patient presents with acute pelvic pain and vaginal discharge. On
exam, cervical motion tenderness is present. Nucleic acid amplification testing
(NAAT) is positive for Chlamydia trachomatis. Which of the following is the most
appropriate treatment regimen?
A. Azithromycin 1 g orally as a single dose
B. Doxycycline 100 mg orally twice daily for 7 days CORRECT
C. Ceftriaxone 500 mg IM once plus doxycycline 100 mg twice daily for 7 days
D. Levofloxacin 500 mg orally once daily for 7 days
RATIONALE: For chlamydial infection, doxycycline 100 mg twice daily for 7 days is preferred
over azithromycin due to higher efficacy, especially in rectal infections. Ceftriaxone is added for
gonorrhea coverage, but this patient has confirmed chlamydia, not gonorrhea. Levofloxacin is an
alternative but not preferred.
Page 3
, Q4 DIFFERENTIATE COMPLEX REPRODUCTIVE HEALTH PRESENTATIONS FOR ACCURATE
DIAGNOSIS AND MANAGEMENT
A multiparous patient at 39 weeks gestation presents with decreased fetal
movement. A biophysical profile (BPP) is 6/10 with normal amniotic fluid volume.
Which of the following is the most appropriate next step in management?
A. Immediate induction of labor
B. Repeat BPP in 24 hours
C. Perform a nonstress test (NST) CORRECT
D. Schedule cesarean delivery
RATIONALE: A BPP of 6/10 is equivocal (borderline) and requires further assessment. An NST is
a reasonable next step to evaluate fetal heart rate reactivity. Immediate induction or cesarean is
not indicated without additional evidence of fetal compromise. Repeating BPP in 24 hours is also
possible, but NST provides immediate information.
Q5 DIFFERENTIATE COMPLEX REPRODUCTIVE HEALTH PRESENTATIONS FOR ACCURATE
DIAGNOSIS AND MANAGEMENT
A patient with polycystic ovary syndrome (PCOS) desires fertility. She has
anovulatory cycles and a BMI of 32. Which of the following is the most appropriate
first-line pharmacologic intervention?
A. Clomiphene citrate 50 mg daily for 5 days starting day 3 of cycle
B. Letrozole 2.5 mg daily for 5 days starting day 3 of cycle CORRECT
C. Metformin 500 mg twice daily
D. Gonadotropin therapy with FSH injections
RATIONALE: Letrozole is now recommended as first-line for ovulation induction in PCOS due to
higher live birth rates and lower multiple pregnancy rates compared to clomiphene. Metformin is
less effective for ovulation induction. Gonadotropins are second-line due to cost and risk of
multiples.
Page 4